ExpreS2ion Biotech Holding AB (publ) EXPRS2.ST Stock
1.29 SEK
{{ price }}
-2.567979%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
66.31M SEK
LOW - HIGH [24H]
1.25
-
1.33 SEK
VOLUME [24H]
132.35K SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-1.33 SEK
ExpreS2ion Biotech Holding AB (publ) Price Chart
ExpreS2ion Biotech Holding AB (publ) EXPRS2.ST Financial and Trading Overview
| ExpreS2ion Biotech Holding AB (publ) stock price | 1.29 SEK |
| Previous Close | 5 SEK |
| Open | 5 SEK |
| Bid | 4.98 SEK x 0 |
| Ask | 5.17 SEK x 0 |
| Day's Range | 4.95 - 5.45 SEK |
| 52 Week Range | 4.15 - 24.44 SEK |
| Volume | 97.86K SEK |
| Avg. Volume | 170.94K SEK |
| Market Cap | 206.5M SEK |
| Beta (5Y Monthly) | 1.267049 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.33 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
EXPRS2.ST Valuation Measures
| Enterprise Value | 124.46M SEK |
| Trailing P/E | N/A |
| Forward P/E | -6.2289157 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 30.997185 |
| Price/Book (mrq) | 2.4467583 |
| Enterprise Value/Revenue | 18.682 |
| Enterprise Value/EBITDA | -0.879 |
Trading Information
ExpreS2ion Biotech Holding AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.267049 |
| 52-Week Change | -56.77% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 24.44 SEK |
| 52 Week Low | 4.15 SEK |
| 50-Day Moving Average | 5.01 SEK |
| 200-Day Moving Average | 10.43 SEK |
EXPRS2.ST Share Statistics
| Avg. Volume (3 month) | 170.94K SEK |
| Avg. Daily Volume (10-Days) | 179.67K SEK |
| Shares Outstanding | 39.94M |
| Float | 35.93M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 1.13% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2145.48% |
| Gross Margin | 17.80% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -73.47% |
| Return on Equity (ttm) | -124.36% |
Income Statement
| Revenue (ttm) | 6.66M SEK |
| Revenue Per Share (ttm) | 0.18 SEK |
| Quarterly Revenue Growth (yoy) | 24.60% |
| Gross Profit (ttm) | 1.07M SEK |
| EBITDA | -141667008 SEK |
| Net Income Avi to Common (ttm) | -131077000 SEK |
| Diluted EPS (ttm) | -3.2 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 71.97M SEK |
| Total Cash Per Share (mrq) | 1.91 SEK |
| Total Debt (mrq) | 2.01M SEK |
| Total Debt/Equity (mrq) | 2.52 SEK |
| Current Ratio (mrq) | 4.717 |
| Book Value Per Share (mrq) | 2.113 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -123912000 SEK |
| Levered Free Cash Flow (ttm) | -89505872 SEK |
Profile of ExpreS2ion Biotech Holding AB (publ)
| Country | Sweden |
| State | N/A |
| City | Horsholm |
| Address | SCION-DTU Science Park |
| ZIP | 2970 |
| Phone | 45 22 22 10 19 |
| Website | https://www.expres2ionbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 28 |
ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops and produces complex proteins for vaccines and diagnostics in Denmark. The company develops capsid virus-like particle COVID-19 vaccine, which is in Phase II clinical trial. It also develops influenza and breast cancer vaccine, which is in Phase II clinical trial, as well as develops malaria vaccine. In addition, the company licenses its ExpreS2 platform to research institutes and pharmaceutical companies. ExpreS2ion Biotech Holding AB (publ) was founded in 2015 is based in Horsholm, Denmark.
Q&A For ExpreS2ion Biotech Holding AB (publ) Stock
What is a current EXPRS2.ST stock price?
ExpreS2ion Biotech Holding AB (publ) EXPRS2.ST stock price today per share is 1.29 SEK.
How to purchase ExpreS2ion Biotech Holding AB (publ) stock?
You can buy EXPRS2.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ExpreS2ion Biotech Holding AB (publ)?
The stock symbol or ticker of ExpreS2ion Biotech Holding AB (publ) is EXPRS2.ST.
Which industry does the ExpreS2ion Biotech Holding AB (publ) company belong to?
The ExpreS2ion Biotech Holding AB (publ) industry is Biotechnology.
How many shares does ExpreS2ion Biotech Holding AB (publ) have in circulation?
The max supply of ExpreS2ion Biotech Holding AB (publ) shares is 51.4M.
What is ExpreS2ion Biotech Holding AB (publ) Price to Earnings Ratio (PE Ratio)?
ExpreS2ion Biotech Holding AB (publ) PE Ratio is now.
What was ExpreS2ion Biotech Holding AB (publ) earnings per share over the trailing 12 months (TTM)?
ExpreS2ion Biotech Holding AB (publ) EPS is -1.33 SEK over the trailing 12 months.
Which sector does the ExpreS2ion Biotech Holding AB (publ) company belong to?
The ExpreS2ion Biotech Holding AB (publ) sector is Healthcare.
ExpreS2ion Biotech Holding AB (publ) EXPRS2.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| First North All-Share DKK FIRSTNORTHDKK | 101.04 DKK 14.82 USD |
-1.33
|
— — | 100.96 DKK 14.8 USD | 102.42 DKK 15.02 USD | — - | — — |
| First North Sweden SEK GI FNSESEKGI | 2001.34 SEK 195.36 USD |
-1.07
|
— — | 1999.37 SEK 195.16 USD | 2020.41 SEK 197.22 USD | — - | — — |
| First North Sweden EUR GI FNSEEURGI | 1616.97 EUR 1767.57 USD |
-1.5
|
— — | 1615.38 EUR 1765.82 USD | 1639.39 EUR 1792.08 USD | — - | — — |
| First North Health Care GI FN20GI | 939.04 EUR 1026.5 USD |
-1.95
|
— — | 937.79 EUR 1025.13 USD | 957.74 EUR 1046.94 USD | — - | — — |
| First North All-Share EUR FIRSTNORTHEUR | 100.98 EUR 110.38 USD |
-1.33
|
— — | 100.89 EUR 110.29 USD | 102.35 EUR 111.88 USD | — - | — — |
| First North Sweden SEK PI FNSESEKPI | 1878.6 SEK 183.37 USD |
+0.16
|
— — | 1870.08 SEK 182.54 USD | 1889.76 SEK 184.46 USD | — - | — — |
| First North Sweden EUR PI FNSEEURPI | 1513.01 EUR 1653.92 USD |
+0.67
|
— — | 1510.95 EUR 1651.67 USD | 1533.41 EUR 1676.23 USD | — - | — — |
| First North Health Care PI FN20PI | 934.74 EUR 1021.8 USD |
-1.95
|
— — | 933.5 EUR 1020.44 USD | 953.35 EUR 1042.15 USD | — - | — — |
| First North All-Share SEK FIRSTNORTHSEK | 126.34 SEK 12.33 USD |
-0.9
|
— — | 126.23 SEK 12.32 USD | 127.53 SEK 12.45 USD | — - | — — |
- {{ link.label }} {{link}}